Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca2+ entry in human pulmonary arterial smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 306, Issue 9, 2014, Pages

  Yamamura, Hisao ^a,b   Yamamura, Aya ^a,c   Ko, Eun A ^a   Pohl, Nicole M ^a   Smith, Kimberly A ^a   Zeifman, Amy ^a   Powell, Frank L ^d   Thistlethwaite, Patricia A ^d   Yuan, Jason X J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c KINJO GAKUIN UNIVERSITY   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Jagged; Notch intracellular domain; Notch receptor; Pulmonary artery; Smooth muscle; Store operated calcium entry

Indexed keywords

GAMMA SECRETASE; JAGGED1; NOTCH RECEPTOR; NOTCH3 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERIAL SMOOTH MUSCLE CELL; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STORE OPERATED CALCIUM ENTRY; UPREGULATION; WESTERN BLOTTING;

JAGGED; NOTCH INTRACELLULAR DOMAIN; NOTCH RECEPTOR; PULMONARY ARTERY; SMOOTH MUSCLE; STORE-OPERATED CALCIUM ENTRY;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PEPTIDE FRAGMENTS; PULMONARY ARTERY; RECEPTORS, NOTCH; SARCOPLASMIC RETICULUM; TIME FACTORS;

EID: 84900558695     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00221.2013     Document Type: Article

References (54)

1. Campos AH, Wang W, Pollman MJ, Gibbons GH. Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation. Circ Res 91: 999-1006, 2002.
2. Chigurupati S, Venkataraman R, Barrera D, Naganathan A, Madan M, Paul L, Pattisapu JV, Kyriazis GA, Sugaya K, Bushnev S, Lathia JD, Rich JN, Chan SL. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res 70: 418-427, 2010.
3. Crosnier C, Attie-Bitach T, Encha-Razavi F, Audollent S, Soudy F, Hadchouel M, Meunier-Rotival M, Vekemans M. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 32: 574-581, 2000.
4. Doi H, Iso T, Shiba Y, Sato H, Yamazaki M, Oyama Y, Akiyama H, Tanaka T, Tomita T, Arai M, Takahashi M, Ikeda U, Kurabayashi M. Notch signaling regulates the differentiation of bone marrow-derived cells into smooth muscle-like cells during arterial lesion formation. Biochem Biophys Res Commun 381: 654-659, 2009.
5. Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT, Klonjkowski B, Berrou E, Mericskay M, Li Z, Tournier-Lasserve E, Gridley T, Joutel A. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 18: 2730-2735, 2004.
6. Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 18: 2474-2478, 2004.
7. Firth AL, Remillard CV, Yuan JX. TRP channels in hypertension. Biochim Biophys Acta 1772: 895-906, 2007.
8. Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J, Thurston G, Yancopoulos GD. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 101: 15949-15954, 2004.
9. 2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 280: H746-H755, 2001.
10. Gridley T. Notch signaling in the vasculature. Curr Top Dev Biol 92: 277-309, 2010.
11. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F, Jones PL, Maitland ML, Michelakis ED, Morrell NW, Newman JH, Rabinovitch M, Schermuly R, Stenmark KR, Voelkel NF, Yuan JX, Humbert M. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54: S10-S19, 2009.
12. 2 in the regulation of ion channels and transporters. Am J Physiol Renal Physiol 293: F1761-F1765, 2007.
13. Hyduk A, Croft JB, Ayala C, Zheng K, Zheng ZJ, Mensah GA. Pulmonary hypertension surveillance-United States, 1980-2002. MMWR Surveill Summ 54: 1-28, 2005.
14. Iso T, Hamamori Y, Kedes L. Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 23: 543-553, 2003.
15. Jones EA, Clement-Jones M, Wilson DI. JAGGED1 expression in human embryos: correlation with the Alagille syndrome phenotype. J Med Genet 37: 658-662, 2000.
16. + channels in mouse pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 293: C928-C937, 2007.
17. Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137: 216-233, 2009.
18. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 18: 2469-2473, 2004.
19. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL, Gridley T. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14: 1343-1352, 2000.
20. 2+ signaling. Am J Physiol Heart Circ Physiol 302: H1546-H1562, 2012.
21. Kyriazis GA, Belal C, Madan M, Taylor DG, Wang J, Wei Z, Pattisapu JV, Chan SL. Stress-induced switch in Numb isoforms enhances Notch-dependent expression of subtype-specific transient receptor potential channel. J Biol Chem 285: 6811-6825, 2010.
22. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, Costa T, Pierpont ME, Rand EB, Piccoli DA, Hood L, Spinner NB. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16: 243-251, 1997.
23. Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P, Macias J, Yuan JX, Jamieson SW, Thistlethwaite PA. Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 15: 1289-1297, 2009.
24. 2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res 95: 496-505, 2004.
25. Loomes KM, Taichman DB, Glover CL, Williams PT, Markowitz JE, Piccoli DA, Baldwin HS, Oakey RJ. Characterization of Notch receptor expression in the developing mammalian heart and liver. Am J Med Genet 112: 181-189, 2002.
26. Loomes KM, Underkoffler LA, Morabito J, Gottlieb S, Piccoli DA, Spinner NB, Baldwin HS, Oakey RJ. The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome. Hum Mol Genet 8: 2443-2449, 1999.
27. Ma XB, Jia XS, Liu YL, Wang LL, Sun SL, Song N, Wang EH, Li F. Expression and role of Notch signalling in the regeneration of rat tracheal epithelium. Cell Prolif 42: 15-28, 2009.
28. McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129: 1075-1082, 2002.
29. Monahan P, Rybak S, Raetzman LT. The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary. Endocrinology 150: 4386-4394, 2009.
30. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54: S20-S31, 2009.
31. Morrow D, Guha S, Sweeney C, Birney Y, Walshe T, O'Brien C, Walls D, Redmond EM, Cahill PA. Notch and vascular smooth muscle cell phenotype. Circ Res 103: 1370-1382, 2008.
32. Morrow D, Scheller A, Birney YA, Sweeney C, Guha S, Cummins PM, Murphy R, Walls D, Redmond EM, Cahill PA. Notch-mediated CBF-1/RBP-Jκ-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am J Physiol Cell Physiol 289: C1188-C1196, 2005.
33. Kip1. J Neurosci Res 87: 3521-3534, 2009.
34. Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B, Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-κB and PPARgamma. Cell Death Differ 9: 842-855, 2002.
35. Nilius B, Owsianik G, Voets T. Transient receptor potential channels meet phosphoinositides. EMBO J 27: 2809-2816, 2008.
36. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, Meltzer PS, Spinner NB, Collins FS, Chandrasekharappa SC. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16: 235-242, 1997.
37. Kip2. EMBO Rep 9: 377-383, 2008.
38. Roca C, Adams RH. Regulation of vascular morphogenesis by Notch signaling. Genes Dev 21: 2511-2524, 2007.
39. + channel activity in human prostate cancer cells: independent modulation of in vitro motility. Prostate Cancer Prostatic Dis 9: 399-406, 2006.
40. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43: 5S-12S, 2004.
41. 2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Pulm Circ 1: 84-94, 2011.
42. Suh BC, Hille B. PIP2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys 37: 175-195, 2008.
43. 2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 283: L144-L155, 2002.
44. Thistlethwaite PA, Li X, Zhang X. Notch signaling in pulmonary hypertension. Adv Exp Med Biol 661: 279-298, 2010.
45. Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122: 2251-2259, 1996.
46. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 108: 161-164, 2001.
47. Wang T, Baron M, Trump D. An overview of Notch3 function in vascular smooth muscle cells. Prog Biophys Mol Biol 96: 499-509, 2008.
48. Wang Y, Deng X, Hewavitharana T, Soboloff J, Gill DL. Stim, ORAI and TRPC channels in the control of calcium entry signals in smooth muscle. Clin Exp Pharmacol Physiol 35: 1127-1133, 2008.
49. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8: 723-730, 1999.
50. - channels contributes to regulating receptor-and storeoperated Ca entry in human pulmonary artery smooth muscle cells. Pulm Circ 1: 269-279, 2011.
51. Yang XR, Lin MJ, Sham JS. Physiological functions of transient receptor potential channels in pulmonary arterial smooth muscle cells. Adv Exp Med Biol 661: 109-122, 2010.
52. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435: 98-104, 2005.
53. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 284: C316-C330, 2003.
54. 2+ in cultured human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 288: C245-C252, 2005.